Alzinova AB’s Post

I am pleased to announce the publication of our latest research paper in IEEE Access, a Q1 journal. The paper, titled “LivMarX: An Optimized Low-Cost Predictive Model using Biomarkers for Interpretable Liver Cirrhosis Stage Classification,” is now available on IEEE Xplore. You can read it here: https://lnkd.in/dbX4nqbF . This research presents an innovative and cost-effective model that leverages biomarkers to provide interpretable classifications of liver cirrhosis stages. Our model not only aims to enhance early detection and treatment but also strives to be accessible and implementable in resource-limited settings, potentially transforming the landscape of liver cirrhosis diagnosis and management. I would like to extend my sincere thanks to my co-authors, Kushal Pendekanti and Dr. Divya Rao for their invaluable contributions and dedication to this project. This achievement would not have been possible without their expertise and collaboration. #Research #Healthcare #LiverCirrhosis #MachineLearning #IEEEAccess #Biomarkers #PredictiveModel

It is fantastic to be back in Switzerland on my way from Zürch to Basel🇨🇭. This is Moa Persson and my second trip down here in a couple of months and the reason is that things are just happening here! The biotech sector seems to be exploding all over this region, with both mastodons of the medical world being here, but also a vast and flourishing ecosystem of smaller start-up's as well as exciting research being done at Universities. This is just the place for Symcel to be and from our meetings with academics and companies, we have a platform that is a perfect fit for this ecosystem! So much work is being done into the research of new #antimicrobials, #phages, and #celltherapy, that our solutions for complex in-vivo-like model systems as well as fast and sensitive detection of bacteria are a perfect match. This will not be our last trip down here! We are ready for so much more synergy with these amazing clusters of #biotechnologyindustry

🌟 As Bio-Europe 2023 rapidly approaches, the excitement is palpable. It's the place to be for those at the forefront of biotech and pharma. Our very own CEO and CSO are among the thought leaders eager to engage in meaningful discussions that push the boundaries of health science. With the clock ticking, we're looking forward to sharing our latest advancements in AI-driven biomarker discovery and discussing how these innovations can catalyze a new era in personalized medicine. 🔬 If you're passionate about making strides in healthcare and curious about the convergence of AI, epigenetics, and multi-omics, don't let this chance slip away. Dr. Tom Stubbs and Dr. Daniel Martin-Herranz will be there, ready to exchange ideas and explore new paradigms. Connect with us at Bio-Europe and be part of the movement towards smarter, more targeted healthcare solutions. #BioEurope #PersonalizedMedicine #HealthTech #Innovation #NetworkingOpportunity #DontMissOut

When challenges arise in the lab, multiplexing delivers. For decades, scientists have sought better ways to research the correlation between the gut microbiome and overall patient health. However, obtaining precise measurements of bacterial groups in the gut microbiome posed challenges due to the need for advanced and expensive technology. Discover, in our most recent white paper, how xMAP Technology was used to create a platform that enabled researchers to measure 48 bacterial taxonomic groups in both gastrointestinal patients and healthy individuals, empowering scientists with the technology needed to develop advanced, affordable testing solutions. #guthealth #biotech #healthscience Find out more in our white paper: https://hubs.li/Q02jRzxC0

𝘐𝘧 𝘢𝘯 𝘢𝘤𝘤𝘶𝘳𝘢𝘵𝘦 "𝘽𝙞𝙤𝙡𝙤𝙜𝙞𝙘𝙖𝙡 𝘼𝙜𝙚" 𝘦𝘹𝘪𝘴𝘵𝘴... W𝘦 𝘢𝘳𝘦 𝘤𝘭𝘰𝘴𝘦𝘳 𝘵𝘩𝘢𝘯 𝘦𝘷𝘦𝘳 𝘵𝘰 𝘶𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥 𝘪𝘵! ⚡ Congratulations to Mahdi Moqri, Chiara Herzog, Jesse Poganik, Kejun Ying 𝘦𝘵 𝘢𝘭, for this awesome milestone, published on Nature Portfolio 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲. 🔎 This review article, titled "𝙑𝙖𝙡𝙞𝙙𝙖𝙩𝙞𝙤𝙣 𝙤𝙛 𝙗𝙞𝙤𝙢𝙖𝙧𝙠𝙚𝙧𝙨 𝙤𝙛 𝙖𝙜𝙞𝙣𝙜", delves into the critical process of confirming the accuracy and reliability of aging biomarkers. - This is vital to: ✅ Understand health trajectories, longevity, and key parameters. ✅Translate basic investigation into validated clinical actionable insights. ✅Set a common standard for further research. ⚠ Challenges include data 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝗶𝘇𝗮𝘁𝗶𝗼𝗻 and 𝗰𝗼𝗺𝗽𝗮𝗿𝗮𝗯𝗶𝗹𝗶𝘁𝘆. ✔ Recommendations emphasize 𝘁𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝘁 𝗱𝗮𝘁𝗮 𝘀𝗵𝗮𝗿𝗶𝗻𝗴, diverse 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 𝘀𝘁𝘂𝗱𝗶𝗲𝘀, and 𝗵𝗮𝗿𝗺𝗼𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻 efforts. ⏺ By benchmarking markers from multiomics data, researchers aim to enhance the robustness and clinical translation of aging biomarkers. 🙌 Exciting times ahead! This kind of milestones pave the way towards a common language in antiaging and longevity research. - Link to the article in the comments section below ⬇ Share your thoughts! #Longevity #Biomarkers #Antiaging #HealthTech #HealthyLongevity

Title: "The Audacity of Hope: Fueling Progress in the Biosciences Sector" The relentless pursuit of cures for the world's most confounding diseases is what makes the biosciences industry such an exhilarating field. One of our most valuable weapons in this fight is the process of drug discovery, a meticulous journey that tests our perseverance, creativity, and innovative thinking. A recently published article (https://lnkd.in/gF6Q4cF3) by Greatness.bio sheds light on this profound process. It highlights how we leverage knowledge about disease mechanisms, explore vast compound libraries, and tweak molecular structures to develop promising drug candidates. The article underscores the challenging yet rewarding journey from a promising compound to an approved, accessible treatment. Importantly, the piece also acknowledges the crucial role of technology and collaboration in accelerating the process. Automation and AI technologies have emerged as powerful allies, enabling us to screen millions of compounds rapidly and effectively. Equally critical are global collaborations, which facilitate the sharing of knowledge and speed up the translation of lab findings into clinical applications. In our quest to cure the incurable, we must remember that real change comes when our breakthroughs are accessible to everyone, everywhere. The article serves as a reminder that while we strive for innovation, we must also advocate for equality in healthcare. Are you ready for the challenge? Join the conversation, deepen your understanding of the exciting work we do, and let's continue striving for greatness. #Innovate4Health #greatnessbio #biotechjobs

As 2023 draws to a close, we are thrilled to reflect on the incredible journey we have had this year at Cellino! This year has been a banner year for our company, and while we can’t capture everything in a single post, here are some key highlights: 📌 Our team made strong technical progress across all tracks, and we grew the team to 55 Cellineers to power our autonomous biomanufacturing platform for personalized regenerative medicine. 📌 Hosting the inaugural Personalized RegenMed Forum was a fantastic experience. The Forum underscored not only that the global personalized regenerative medicine ecosystem is poised for significant growth—with 5 INDs approved, but also that by convening and addressing challenges collectively, we will all move faster together.  📌 It was an honor for our CEO Nabiha Saklayen to speak at the National Academies of Science, Engineering, and Medicine workshop on Automation and Algorithms in Regenerative Medicine Manufacturing. Cellino is all-in on the need for AI and automation to bring scale to the biomanufacturing industry. 📌 What a privilege to join the Future of Health Summit panel on cell therapy innovation and costs alongside Peter Marks of the FDA! 🚀 The convergence of biology, engineering, and AI will bring great advancements in personalized regenerative medicine, and we are proud to address this challenge and extend lifespan and healthspan for patients.   📌 Winning the ARPA-H Dash Scalable Solutions category showed that the public is excited about the bright future that Cellino is building to bring “Your Cells, Your Cure” to patients—and we’re excited, too!  📌 Our team traversed the globe this year to explore collaboration opportunities and share Cellino’s vision, from coast to coast across the U.S. to Japan, France, South Korea, Finland, and beyond. It has been an amazing year that has brought us deep gratitude for pursuing our bold mission, and we are pumped for 2024. Let’s go! 🚀🚀 #CellinoBio #YearinReview #Biotech #Biotechnology #BiotechInnovation #Healthcare #LifeSciences #Innovation #Collaboration #Team #Biomanufacturing #PersonalizedMedicine #Therapeutics #RegenMed #YourCellsYourCure

Some people say your gut is your second brain, so better keep it healthy! Our most recent white paper is all about how our xMAP Technology is used to create a platform that enables researchers to measure 48 bacterial taxonomic groups in both gastrointestinal patients and healthy individuals, empowering scientists with the technology needed to develop advanced, affordable testing solutions. You can read all about it via the link below, happy reading! #luminex #multiplexing #guthealth #research #microbiome

🔬 On the Verge of Breakthroughs at Bio-Europe 2023 🔬 The countdown to Bio-Europe 2023 has nearly reached its end, and anticipation is at an all-time high! Hurdle is poised to unveil a spectrum of advancements that redefine health technology as we know it. Our array of innovations transcends beyond biological age testing, encompassing a broad suite of multi-omics and epigenetic breakthroughs designed to transform patient care and precision medicine. From cost-effective diagnostic solutions to revolutionary biomarker discoveries, we're bridging the gap between next-gen science and practical healthcare applications. It’s not just about making strides in one area but advancing a holistic approach to modern medicine. Don’t miss the chance to be part of these discussions. Dr. Tom Stubbs (our CEO) and Dr. Daniel Elias Martin-Herranz (our CSO) will be on-site spearheading conversations on the future of diagnostics and personalized medicine at BIO-Europe tomorrow. Be there to witness the convergence of expertise and innovation. Let’s embark on this transformative journey together. #HealthTech #Innovation #BIOEurope #HurdleInnovation #PrecisionMedicine #Epigenetics

🔬 Exciting Developments in #LifeScience! 🔍 Thrilled to share the latest breakthroughs shaping the future of life sciences. 🌱 From innovative research to groundbreaking discoveries, our industry is pushing boundaries and revolutionizing healthcare. 💊 🌐 Let's celebrate the dedicated scientists, researchers, and professionals driving progress in life science. 🙌 Your relentless pursuit of knowledge is transforming the way we understand and treat diseases. Together, we're building a healthier and more sustainable world. 🌍 🚀 Whether you're working in biotech, pharmaceuticals, genomics, or any other facet of life science, your contributions are making a significant impact. Share your insights and achievements below! 👇 #LifeScienceInnovation #Biotechnology #HealthcareRevolution #ResearchMatters #ScienceCommunity #Innovation #HealthTech #BiotechAdvancements #Resonacle